Lymph node metastasis-related gene signature shows good performance in predicting prognosis and immune infiltration in cervical cancer.

The lymph node metastasis-related predictive signature based on and showed good performance in predicting the survival outcomes of patients with cervical cancer. The risk score of the predictive signature was related to genetic variation and immune infiltration, which could guide immunotherapy and chemotherapy strategies.